Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.425 USD | -4.71% | +17.40% | -3.39% |
May. 16 | Transcript : AIM ImmunoTech Inc., Q1 2024 Earnings Call, May 16, 2024 | |
May. 15 | AIM ImmunoTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 172K | Sales 2025 * | 1.78M | Capitalization | 24.28M |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -25M | EV / Sales 2024 * | 141 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 13.6 x |
P/E ratio 2024 * |
-0.97
x | P/E ratio 2025 * |
-0.97
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.99% |
Latest transcript on AIM ImmunoTech Inc.
1 day | -4.71% | ||
1 week | +17.40% | ||
Current month | +17.40% | ||
3 months | +10.68% | ||
6 months | -24.26% | ||
Current year | -3.39% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.425 | -4.71% | 499,532 |
24-06-06 | 0.446 | +18.62% | 2,844,868 |
24-06-05 | 0.376 | -1.05% | 259,552 |
24-06-04 | 0.38 | +7.65% | 252,378 |
24-06-03 | 0.353 | -2.49% | 160,125 |
Delayed Quote Nyse, June 07, 2024 at 04:10 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.39% | 24.28M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- AIM Stock